Source link : https://newshealth.biz/health-news/subcutaneous-lecanemab-maintenance-dosing-for-alzheimers-supported-by-new-data/
(MedPage Today) — TORONTO — An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer’s disease, researchers said here. Continued… Source link : https://www.medpagetoday.com/meetingcoverage/aaic/116807 Author : Publish date : 2025-08-03 17:53:00 Copyright for syndicated content belongs to the linked Source.
The post Subcutaneous Lecanemab Maintenance Dosing for Alzheimer’s Supported by New Data first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-03 17:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8